Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Inhye Park has been awarded a Novo Nordisk Postdoctoral Research Fellowship to research the biology of resident vascular macrophages in atherosclerosis.

Inhye Park

Atherosclerosis is a chronic inflammatory disease that causes the build-up of plaques in the artery walls and is the underlying cause of cardiovascular mortality. Inhye’s fellowship will allow her to investigate the mechanism of action of resident macrophages in the artery, which are thought to alleviate inflammation and facilitate cholesterol metabolism in the vessel wall. She will use bioinformatics methods for target discovery and in vitro and in vivo validation using iPSC-derived macrophages and murine models for her new project.

“If we can identify the molecular mechanism that regulates athero-protective properties in resident vascular macrophages, we can use this to identify new potential therapeutic targets for attenuating atherogenesis. This is a huge opportunity to address one of the leading causes of cardiovascular mortality and I’m grateful to Novo Nordisk for their support of this project,” said Inhye. 

The project is a collaboration between the Kennedy Institute of Rheumatology and the Novo Nordisk Research Centre Oxford.

Similar stories

Fiona Powrie honoured by British Society for Immunology

Fiona Powrie was one of four researchers from the University of Oxford recognised for their outstanding contributions to immunology with Honorary Lifetime Membership of the British Society for Immunology.

The Kennedy Institute scoops sustainability award

A new roof extension was awarded the 2021 Green Award for Sustainability by the Oxford Preservation Trust alongside a Certificate in the New Building category.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

A drug being trialled to treat cancer, could be the key to reducing gut inflammation

Published in Nature Communications, a new study reveals a new signalling pathway behind macrophage inflammatory activity

Single-cell ancestry vaccine research funded by the Chan Zuckerberg Initiative

The Chan Zuckerberg Initiative (CZI) has provided $2 million in funding to investigate how our ancestry and diversity influence the way that vaccines work in our cells.

Chan Zuckerberg Initiative funding awarded to build a globally inclusive musculoskeletal map

NDORMS researchers and several international collaborators have been awarded funding from the Chan Zuckerberg Initiative to deliver an ancestrally diverse musculoskeletal atlas of healthy tissues.